Development -- Parsons et al. 129 (14): 3505 Figure IG2

(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 2. Removal of dystroglycan protein leads to abnormal development. Embryos injected with control MO at 24 hpf (A) and 48 hpf (E) and with a dystroglycan MO at 24 hpf (B) and 48 hpf (F). (C,D,G,H) Staining for dystroglycan in control (C,G) and dystroglycan morphant (D,H) embryos at 24 hpf (C,D) and 48 hpf (G,H).